Gene · 55737
Papers2,077
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,077
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The crucial role of VPS35 and SHH in Parkinson's disease: Understanding the mechanisms behind the neurodegenerative disorder. | Brain Res | 2024 | 39197569 | PubTator, text mining | PubMed |
| Correction to Supporting Information for Chen et al., Parkinson's disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration. | Proc Natl Acad Sci U S A | 2024 | 39186660 | PubTator, text mining | PubMed |
| VPS35 or retromer as a potential target for neurodegenerative disorders: barriers to progress. | Expert Opin Ther Targets | 2024 | 39175128 | PubTator, text mining | PubMed |
| Structural basis for coupling of the WASH subunit FAM21 with the endosomal SNX27-Retromer complex. | Proc Natl Acad Sci U S A | 2024 | 39116126 | PubTator, text mining | PubMed |
| Parkinson's disease variant detection and disclosure: PD GENEration, a North American study. | Brain | 2024 | 39074992 | PubTator, text mining | PubMed |
| Parkinson's Disease Gene Screening in Familial Cases from Central and South America. | Mov Disord | 2024 | 39051491 | PubTator, text mining | PubMed |
| Exploring the triad: VPS35, neurogenesis, and neurodegenerative diseases. | J Neurochem | 2024 | 39022884 | PubTator, text mining | PubMed |
| Identifying pleiotropic genes via the composite test amidst the complexity of polygenic traits. | Brief Bioinform | 2024 | 39007593 | PubTator, text mining | PubMed |
| Genome-wide comparative analyses highlight selection signatures underlying saline adaptation in Chilika buffalo. | Physiol Genomics | 2024 | 38949516 | PubTator, text mining | PubMed |
| Dysregulation of SNX1-retromer axis in pharmacogenetic models of Parkinson's disease. | Cell Death Discov | 2024 | 38886344 | PubTator, text mining | PubMed |
| Retraction Note: Vacuolar protein sorting 35 (VPS35) acts as a tumor promoter via facilitating cell cycle progression in pancreatic ductal adenocarcinoma. | Funct Integr Genomics | 2024 | 38750380 | PubTator, text mining | PubMed |
| Retromer-mediated recruitment of the WASH complex involves discrete interactions between VPS35, VPS29, and FAM21. | Protein Sci | 2024 | 38607248 | PubTator, text mining | PubMed |
| The Legionella pneumophila effector DenR hijacks the host NRas proto-oncoprotein to downregulate MAPK signaling. | Cell Rep | 2024 | 38568811 | PubTator, text mining | PubMed |
| Identification of potential cell death-related biomarkers for diagnosis and treatment of osteoporosis. | BMC Musculoskelet Disord | 2024 | 38528539 | PubTator, text mining | PubMed |
| Integrated analysis of disulfidptosis-related immune genes signature to boost the efficacy of prognostic prediction in gastric cancer. | Cancer Cell Int | 2024 | 38528532 | PubTator, text mining | PubMed |
| Stabilization of the retromer complex: Analysis of novel binding sites of bis-1,3-phenyl guanylhydrazone 2a to the VPS29/VPS35 interface. | Comput Struct Biotechnol J | 2024 | 38487369 | PubTator, text mining | PubMed |
| The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease. | Cell Mol Life Sci | 2024 | 38409392 | PubTator, text mining | PubMed |
| Retromer-dependent lysosomal stress in Parkinson's disease. | Philos Trans R Soc Lond B Biol Sci | 2024 | 38368937 | PubTator, text mining | PubMed |
| VPS35 and retromer dysfunction in Parkinson's disease. | Philos Trans R Soc Lond B Biol Sci | 2024 | 38368930 | PubTator, text mining | PubMed |
| The association of GNB5 with Alzheimer disease revealed by genomic analysis restricted to variants impacting gene function. | Am J Hum Genet | 2024 | 38354736 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55737/papers?page=5